1
Re-treatment Safety of Radium-223 Dichloride in Castration-resistant Prostate Cancer With Bone Metastases
Condition(s):Prostatic NeoplasmsLast Updated:March 26, 2018Completed
Radium 223 Dichloride, Xofigo, BAY88-8223: 42 Clinical Trials, Page 1 of 5
Hide Studies Not Open or Pending
2
Phase Ib Study of Radium Ra 223 Dichloride in Combination With Paclitaxel in Cancer Subjects With Bone Lesions
Condition(s):Neoplasms; Bone DiseasesLast Updated:November 30, 2016Completed
3
EPIX, a Study to Gather More Information About Characteristics of Patients and Other Factors Which May Contribute to Survival Over a Long Period of Time in Patients With Metastatic Castration-resistant Prostate Cancer (mCRPC) Treated With Radium-223 (Xofigo)
Condition(s):Metastatic Castration Resistant Prostate Cancer (mCRPC)Last Updated:January 15, 2021Active, not recruiting
4
A Study to Learn More About How Radium-223 Affects the Quality of Life of Colombian Patients With Prostate Cancer That Has Not Responded to Testosterone Lowering Treatment and Has Spread to the Bones, and to Better Understand Its Safety
Condition(s):Prostate CancerLast Updated:January 13, 2021Not yet recruiting
5
Non-interventional Study With Ra-223 Dichloride Assessing Overall Survival and Effectiveness Predictors for mCRPC Patients in a Real Life Setting in Germany
Condition(s):Prostatic Neoplasms, Castration-ResistantLast Updated:September 25, 2020Completed
6
Study to Gather Information on the Safety and How Radium-223 Dichloride, an Alpha Particle-emitting Radioactive Agent, Works Under Routine Clinical Practice in Taiwan in Patients With Castration-resistant Prostate Cancer (CRPC) Which Has Spread to the Bone
Condition(s):Castration-resistant Prostate CancerLast Updated:December 22, 2020Recruiting
7
Observational Study for the Evaluation of Long-term Safety of Radium-223 Used for the Treatment of Metastatic Castration Resistant Prostate Cancer
Condition(s):Metastatic Castration-resistant Prostate CancerLast Updated:December 24, 2020Active, not recruiting
8
Radium-223 Dichloride Asian Population Study in the Treatment of CRPC Patients With Bone Metastasis
Condition(s):Prostatic NeoplasmsLast Updated:September 19, 2018Completed
9
Standard Dose Versus High Dose and Versus Extended Standard Dose Radium-223 Dichloride in Castration-resistant Prostate Cancer Metastatic to the Bone
Condition(s):Prostatic NeoplasmsLast Updated:July 12, 2019Completed
10
A Study to Assess How Radium-223 Distributes in the Body of Patients With Prostate Cancer Which Spread to the Bones
Condition(s):Bone Metastatic Castration-resistant Prostate CancerLast Updated:December 31, 2020Recruiting